Frazier Life Sciences X L.P. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-17 10:28 am Purchase |
2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 16,416,751 15.300% |
3,784,713 (+29.96%) |
Filing |
| 2024-02-21 11:11 am Unchanged |
2024-02-16 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 12,632,038 14.200% |
0 (Unchanged) |
Filing |
| 2023-08-15 4:02 pm Purchase |
2023-08-11 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 12,632,038 15.300% |
1,485,807 (+13.33%) |
Filing |
| 2023-06-09 3:47 pm Purchase |
2023-06-07 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 11,146,231 13.500% |
11,146,231 (New Position) |
Filing |